Patents
Patents for C07C 317 - Sulfones; Sulfoxides (15,874)
10/2007
10/31/2007EP1390342B1 Substituted aromatic amide derivatives, intermediates thereof, agrohorticultural insecticide containing thereof and method for the use thereof
10/31/2007EP1246795B1 Antibacterial agents
10/31/2007EP0910564B1 D-amino acid derived inhibitors of cysteine and serine proteases
10/31/2007CN101062910A Preparation method of 2-amino ethyl-2'-sulfonyl-hydroxide ethylsulfuric acid ester
10/30/2007US7288567 Inhibitors of histone deacetylase
10/25/2007US20070249853 Colorless, photostable, broad UV-A sunscreen agent compounds based on bis(4-aminophenyl)-2-cyanoacrylates) where the amino group on the phenyl forms an amide, carbamate, or sulfonamide in the linking group; also corresponding cyanoacrylamide and 1-cyanovinylsulfones
10/24/2007EP1846363A2 Adamantyl derivatives as inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
10/24/2007CN101058554A Chemical synthesis method for substituting alpha, beta unsaturated ketone by sulphonyl
10/24/2007CN101058553A Method of synthesizing E-beta-bromo-gamma-hydroxymethylenesulphone
10/23/2007US7285686 Process for the preparation of 1,3-substituted indenes
10/23/2007US7285678 Dissolving in aqueous solution; filtration; absorption using activated carbon; hydrolysis impurities
10/23/2007US7285565 E.g., 3-(2-(4-[(2-aminosulfonyl)phenyl]benzoylamino)phenoxy)benzamidine; 7-(2-(4-[(2-aminosulfonyl)phenyl]benzoylamino)-4-trifluoromethylphenoxy)1-aminoisoquinoline; and 3-hydroxycarbonyl-2-(4-[(2-aminosulfonyl)phenyl]phenylcarbonylamino)phenoxynaphthalene; highly selective
10/18/2007WO2007118041A1 Compounds which modulate the cb2 receptor
10/18/2007WO2007117027A1 Process for the production of organic oxides
10/18/2007US20070244197 Bactericide against gramnegative bacteria; respiratory system disorders
10/18/2007US20070244161 Novel mercaptophenyl naphthyl methane compounds and synthesis thereof
10/18/2007US20070243612 Novel Compounds for Modulating Cell Proliferation
10/18/2007US20070240609 2-hydroxy-1-(4-hydroxymethyl-phenyl)-2-methyl-propan-1-one, have higher reactivity at the benzylic hydroxy group and do not have a tendency to yellowing; photocurable composition for pigmented or non-pigmented varnish surface coatings
10/18/2007CA2643863A1 Compounds which modulate the cb2 receptor
10/17/2007EP1844780A2 Derivatives of aryl-quinazoline/aryl-2-amino-phenyl methanone which promote the release of parathyroid hormone
10/17/2007EP1687266B1 Monomer compound, graft copolymer compound, production method thereof, polymer electrolyte membrane, and fuel cell
10/17/2007EP0787122B9 Calcium receptor-active compounds
10/17/2007CN101056842A Prodrugs of (2R)-2-propyloctanoic acid for treatment of stroke
10/17/2007CN100343228C Selective prepn process of single antimer of 2-dibenzylsulfenyl-acetamide with higher antimer
10/16/2007US7282592 Resorcinol derivatives
10/16/2007US7282502 S,N-diarylsulfonamide derivatives; treating inflammatory diseases such as Celiac's disease, Crohn's disease or colitis; N-(2-Benzoyl-4-chloro-phenyl)-4-chloro-benzenesulfonamide; N-[4-Chloro-2-(pyridin-2-ylsulfanyl)-phenyl]-4-isopropyl-benzenesulfonamide
10/16/2007US7282316 Sulfonyldiazomethane compounds, photoacid generator, resist materials and patterning using the same
10/11/2007WO2007112844A1 Novel crystalline polymorphs of 3-chloro-n2-[(1s)-1-methyl-2-(methylsulfonyl)ethyl]-n1-{2-methyl-4-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl}phthalamide
10/11/2007US20070238763 Urea derivatives as integrin a4 antagonists
10/11/2007DE102006014491A1 New modified crystalline forms of 3-chloro-N2-((1S)-1-methyl-2-(methy l-sulfonyl)ethyl)-N1-(2-methyl-4-(1,2,2,2-tetrafluoro-1-(trifluoromet hyl)-ethyl)phenyl)phthalamide, useful for producing insecticidal active compositions
10/10/2007EP1841420A2 Treatment of drug-resistant proliferative disorders
10/10/2007CN100341851C Processes for the preparation of diphenylsulfone compounds
10/10/2007CN100341496C Preventive or therapeutic agent for kidney disease
10/09/2007US7279478 Cathepsin cysteine protease inhibitors
10/09/2007US7279470 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
10/09/2007CA2204527C 2,2-dichloralkane-carboxylic acids, processes for their production and pharmaceutical agents containing these
10/03/2007EP1511722B1 Phenylcyclohexylpropanolamine derivatives, preparation and therapeutic application thereof
10/03/2007CN101048370A Optically active phthalamides
10/03/2007CN101048369A Biphenyloxyacetic acid derivatives for the treatment of respiratory disease
10/02/2007US7276637 Cycloaddition of a 2-trialkylsilyloxybutadiene to a vinyl derivative to form a silyl enol ether; hydrolysis to form cyclohexanone; oxidation, reduction, homologation, neutralization, cyclization; secretase inhibitors
10/02/2007CA2096407C Retroviral protease inhibitors
09/2007
09/27/2007WO2007109175A1 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
09/27/2007US20070225520 Stereoselective Synthesis of a 4,4-Disubstituted Cyclohexanepropanoic Acid
09/27/2007US20070225365 Cetp Inhibitors
09/26/2007EP1763499B1 New photoinitiators
09/26/2007EP1383750B1 Urea derivatives as integrin alpha 4 antagonists
09/26/2007EP1341753B1 Cyclohexyl(alkyl)-propanolamines, preparation method and pharmaceutical compositions containing same
09/26/2007CN100339365C 3-amido-4-alkylamino lauseto neu preparation method
09/25/2007US7273952 Substituted C-cyclohexylmethylamine derivatives
09/25/2007US7273863 Benzophenones as inhibitors of reverse transcriptase
09/19/2007EP1673338B1 Fatty acid compounds, preparation and uses thereof
09/19/2007CN101039922A 3-triazolylphenyl sulfide derivative and insecticide/acaricide/nematici`de containing the same as active ingredient
09/19/2007CN101039902A Aminoalcohol derivatives
09/19/2007CN101039901A Process for making phenoxy benzamide compounds
09/19/2007CN101037405A Preparation method of aniline derivative containing 2-hydroxyethylsulfonyl
09/19/2007CN101037404A Preparation method of para-(beta-Ethyl Sulfonyl Sulfate) aniline sulfonic acid
09/19/2007CN100338031C Compounds and methods for synthesis and therapy
09/18/2007USRE39850 Aryl amide, -sulfonamide, or -urea derivatives; antiproliferative, antitumor, anticarcinogenic, and/or antimetastasis agents
09/18/2007US7271289 4'-(azetidin-1-ylcarbonyl)-N-cyclopropyl-5-fluoro-6-methyl-1,1'-biphenyl-3-carboxamide; enzyme inhibitors for the treatment of certain diseases and conditions; chemical synthesis
09/18/2007US7271228 Ionic perfluorovinyl compounds and their uses as components of ionic conductors of the polymer type, of selective membranes or of catalysts
09/18/2007US7271197 prophylaxis and treatment of respiratory diseases; compounds having potent and selective stimulant action at beta 2-adrenoreceptors and having an advantageous profile of action
09/18/2007CA2416229C Alpha-acyl and alpha-heteroatom-substituted benzene acetamide glucokinase activators
09/18/2007CA2287991C New benzylamine derivatives and phenylethylamine derivatives, process for preparing them and their use as medicaments
09/18/2007CA2262966C Method for reducing .alpha.-aminoketone
09/18/2007CA2211982C Substituted indanylidineacetylguanidines, process for their preparation,their use as medicaments or diagnostic and medicaments containing them
09/18/2007CA2149285C Perfluoroalkyl-substituted benzoylguanidines, a process for their preparation, their use as a medicament or diagnostic agent, and a medicament containing them
09/13/2007WO2007103996A1 2-(aryloxy)acetamide factor viia inhibitors useful as anticoagulants
09/13/2007WO2007103719A2 MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
09/13/2007WO2007103221A2 An improved process for the preparation of armodafinil
09/13/2007US20070213348 Chemical Compounds
09/13/2007US20070213333 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate
09/13/2007US20070213329 Sulphones which modulate the action of gammasecretase
09/13/2007US20070213316 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives
09/13/2007CA2634133A1 An improved process for the preparation of armodafinil
09/12/2007EP1831405A1 Composition for the treatment of leather
09/12/2007EP1831159A1 Tetralin and indane derivatives and uses thereof
09/12/2007EP1379239B1 N-(2-arylethyl) benzylamines as antagonists of the 5-ht6 receptor
09/12/2007CN101035767A Substituted phenylacetamides and their use as glucokinase activators
09/11/2007US7268152 Antiinflammatory agents; antiallergens; antiproliferative agents
09/11/2007US7268132 Thio substituted with a hetero multiring group; sleepiness, promotion of wakefulness, Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, attention deficit hyperactivity disorder
09/11/2007CA2426275C Ectoparasitic insect pest controllers for animals and their usage
09/11/2007CA2070419C Synthesis and use of amino acid fluorides as peptide coupling reagents
09/07/2007WO2007100074A1 1-fluoro-1,1-bis(phenylsulfonyl)methane and method for producing same
09/07/2007WO2007099450A2 Process for the preparation of 2-nitro substituted benzoic acids
09/07/2007WO2006041888A3 Substituted aryl or heteroarylsulfonylbutanamides for use as anti-inflammatory agents
09/05/2007CN101031539A Substituted arylalkanoic acid derivatives and use thereof
09/05/2007CN101031289A Indoleacetic acid and indenacetic acid derivatives as therapeutic agents with reduced gastrointestinal toxicity
09/04/2007US7265230 Herbicides
08/2007
08/30/2007WO2007098273A2 Novel crystalline forms of armodafinil and preparation thereof
08/30/2007WO2007070238A3 Processes for the preparation of modafinil and analogs thereof
08/30/2007US20070203218 glutamate receptors agonists; especially to treat psychotic conditions, including schizophrenia and enhancement of cognition; N-{-2-[4-(6-fluoro-3-pyridinyl)phenyl]cyclopropyl}-2-propanesulfonamide
08/30/2007US20070203207 Heteroaromatic glucokinase activators
08/30/2007US20070203205 treatment and/or prevention of adverse conditions of the central nervous system, including sleep disorders such as insomnia, psychotic disorders such as schizophrenia and psychiatric disorders such as anxiety; example (1S)-1-[2-({4-[(E)-2-(4-fluorophenyl)vinyl]phenyl}sulfonyl)phenyl]ethanol
08/30/2007US20070202761 fluorinated acrylic polymers having excellent water repellency, oil repellency and antifouling properties; surface treatment of textiles, masonry, filters, protective devices and fuel cells
08/29/2007EP1824817A1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists
08/28/2007US7262317 Elastase inhibitor; respiratory system disorders; hypotensive agents; administering by injection
08/28/2007CA2210889C Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
08/23/2007WO2007093772A1 Process for the preparation of 2- [vinyl (hetero) aryl sulphonyl] ethanol derivatives
08/23/2007WO2007093211A1 Process for the treatment of an aqueous mixture comprising a dipolar aprotic compound
08/23/2007WO2007079010A3 Carbonates of fenicol antibiotics
1 ... 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 ... 159